PMID: 7022272Jan 1, 1981Paper

Animal models and human depressive disorders

Neuroscience and Biobehavioral Reviews
R J Katz

Abstract

Clinical depressive disorders are complex in presentation, dissimilar in origins and course, and often pleomorphic in character. An adequate understanding of their origins, biological substrates, and amenability to established and novel forms of therapy demands biological and social interventions which cannot always readily or ethically be carried out in a clinical setting. One useful complementary approach to clinical research utilizes preclinical models for laboratory investigations in parallel. The present paper reviews current approaches to modelling depression using animals, with particular emphasis upon phylogenetic constraints, systematic validity and reliability, and nosological limitations. Preclinical models are useful and necessary adjuncts for adequately understanding depression in humans. However, their utility remains a direct function of a continuing dialogue between clinical and laboratory research, and demands scrupulous observation and methodological rigor on the part of both clinicians and experimental researchers.

References

Jan 1, 1977·Psychoneuroendocrinology·N HatotaniI Kitayama
Mar 1, 1978·Archives of General Psychiatry·S J SuomiW T McKinney
May 1, 1979·Developmental Psychobiology·W P SmothermanS Levine
Jun 28, 1979·Psychopharmacology·P D HrdinaR Stretch
Dec 1, 1979·Physiology & Behavior·M B HennessyS Levine
May 1, 1977·Behavioral Biology·A Altenor, E A DeYoe
Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Nov 1, 1978·Brain Research Bulletin·J PankseppA J Kastin
Feb 1, 1978·Psychosomatic Medicine·I C Kaufman, A J Stynes
Jan 1, 1978·Physiology & Behavior·S LevineW P Smotherman
Apr 1, 1979·Journal of Comparative and Physiological Psychology·H AnismanL S Sklar
Jul 1, 1979·Psychoneuroendocrinology·K D CairncrossA F Wren
Nov 16, 1979·European Journal of Pharmacology·J GarzónJ Del Rio
Apr 1, 1977·The Journal of General Psychology·H R WagnerI L Cote
Oct 1, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Feb 1, 1978·Journal of Abnormal Psychology·M H Willis, P H Blaney
Feb 1, 1978·Journal of Abnormal Psychology·A M BuchwaldC S Cole
Feb 1, 1978·Journal of Abnormal Psychology·L R Huesmann
Dec 1, 1978·Pharmacology, Biochemistry, and Behavior·A I LeshnerT B van Wimersma Greidanus
Oct 1, 1975·Journal of Abnormal Psychology·S J SuomiH F Harlow
Apr 1, 1976·Journal of Child Psychology and Psychiatry, and Allied Disciplines·S J SuomiG C Ruppenthal
Jun 1, 1976·Archives of General Psychiatry·J K LewisG W Kraemer
Jul 1, 1976·Life Sciences·G W KraemerJ Kemnitz
Mar 1, 1975·Psychosomatic Medicine·S H AckermanH Weiner
Apr 1, 1975·Journal of Experimental Psychology. Animal Behavior Processes·R A Rosellini, M E Seligman
Feb 1, 1975·Journal of Comparative and Physiological Psychology·M E Seligman, G Beagley
Feb 1, 1975·Journal of Comparative and Physiological Psychology·M E SeligmanM J Kozak
Sep 1, 1975·Pharmacology, Biochemistry, and Behavior·J Rush, J Mendels
May 1, 1973·Developmental Psychobiology·B C Jones, D L Clark
Apr 1, 1974·Archives of General Psychiatry·J Mendels, A Frazer
Jun 1, 1972·The British Journal of Psychiatry : the Journal of Mental Science·I OswaldD L Dunleavy

❮ Previous
Next ❯

Citations

Jan 1, 1987·Psychopharmacology·H M Barros, J R Leite
Jan 1, 1984·Psychopharmacology·P Willner
Dec 14, 2011·Journal of Neural Transmission·Tatiana BarichelloJoão Quevedo
Aug 26, 2009·Neurotoxicity Research·Clarissa M ComimFelipe Dal-Pizzol
Jul 1, 1985·Biological Psychiatry·J A Jesberger, J S Richardson
Jan 1, 1988·Physiology & Behavior·E L Rodríguez EchandíaL N Fracchia
Jul 1, 1992·Physiology & Behavior·I SchelstraeteM H Weyers
Jun 1, 1982·Pharmacology, Biochemistry, and Behavior·R J Katz, M Sibel
Aug 1, 1986·Pharmacology, Biochemistry, and Behavior·E EdwardsF A Henn
Mar 1, 1989·Pharmacology, Biochemistry, and Behavior·M F PignatielloR D Olson
Jun 1, 1989·Pharmacology, Biochemistry, and Behavior·A M Rosenwasser
Aug 1, 1990·Pharmacology, Biochemistry, and Behavior·R E MustyR H Lenox
Feb 1, 1991·Pharmacology, Biochemistry, and Behavior·N N KudryavtsevaL A Koryakina
Aug 1, 1992·Pharmacology, Biochemistry, and Behavior·J Velazquez-Moctezuma, O Diaz Ruiz
Nov 1, 1993·Pharmacology, Biochemistry, and Behavior·T NaruoN Ogawa
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·K A Roth, R J Katz
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·R J Katz, S Hersh
Jan 1, 1986·Neuroscience and Biobehavioral Reviews·J C Tucker, S E File
Jan 1, 1986·Neuroscience and Biobehavioral Reviews·S E File, J C Tucker
Jan 1, 1990·Pharmacology & Therapeutics·P Willner
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·N Sitaram, S Gershon
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·J F Nash, R P Maickel
Jun 1, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Donn A Simmons, Patricia A Broderick
Jan 1, 1993·Neuroscience and Biobehavioral Reviews·D H Overstreet
Jul 1, 1984·Behavioral and Neural Biology·B ThierryP Simon
Jan 1, 1996·Pharmacology & Therapeutics·W C Duncan
Oct 9, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nassia Kioukia-FougiaZeta Papadopoulou-Daifoti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.